Skip to content
Use caution Drug recall · FDA · Published January 22, 2014

Fresenius Kabi Recalls Heparin Sodium Injection Due to Subpotency

Fresenius Kabi USA recalls specific lots of Heparin Sodium Injection because the drug may be subpotent, posing a risk of ineffective treatment.

🇺🇸 FDA recall #D-1148-2014DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC3159 Staley Rd · Grand Island, NY 14072-2028
✎ GovInfoNow plain-language explainer

What happened, in plain English

Fresenius Kabi USA, LLC is recalling one lot of Heparin Sodium Injection, USP 10,000 USP units per 10 mL. The product was found to be subpotent at the 18-month time point, meaning it may not contain enough active ingredient to work as intended. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/46305-fresenius-kabi-usa-llc-recalls-heparin-sodium-injection-usp-10.

Source Summary by GovInfoNow · govinfonow.com/recall/46305-fresenius-kabi-usa-llc-recalls-heparin-sodium-injection-usp-10 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1148-2014

Cite this page

“Fresenius Kabi Recalls Heparin Sodium Injection Due to Subpotency.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46305-fresenius-kabi-usa-llc-recalls-heparin-sodium-injection-usp-10. Based on FDA recall #D-1148-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1148-2014%22&limit=1).

Why it’s dangerous

The recalled vials are classified as 'subpotent,' which means the concentration of heparin is lower than labeled. If used, the patient may not receive the therapeutic anticoagulant effect needed to prevent or treat blood clots, potentially leading to serious health complications.

Who’s affected

Patients who have been prescribed or received Heparin Sodium Injection for intravenous (IV) or subcutaneous (SC) use. Individuals relying on this specific medication for blood clotting management are at risk of receiving an ineffective dose.

How to tell if you have this one

Check if you have Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) in a multi-dose vial. Specifically look for NDC 63323-540-11, Lot Number 6004137, and an expiration date of 06/2014.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your vial matches NDC 63323-540-11, Lot Number 6004137, and expiration date 06/2014.

  2. Contact Your Healthcare Provider

    Speak with your doctor or pharmacist immediately to discuss alternative treatments if you possess the recalled lot.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.3 years after the firm started it.

1. Firm started the recall: Jan 22, 201412. FDA classified it Class II: Mar 5, 201423. Published in FDA’s Enforcement Report: Mar 12, 201434. FDA terminated the recall: May 24, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Fresenius Kabi recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1148-2014 (January 22, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1148-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA